Prostate-specific antigen (PSA)-based screening for prostate cancer has received mixed reviews from different organizations, says William G. Nelson, M.D., Ph.D., director of the Johns Hopkins Kimmel Cancer Center. Today, the United States Preventive Services Task Force has posted draft recommendations for prostate screening that encourage men ages 55 - 69 to make individual decisions about […]
vw
Johns Hopkins Student Wins Top Prize For Research on Lethal Brain Tumors in Children
Posted by | Childhood Cancer, ResearchJohns Hopkins undergraduate student Sabrina Wang won first place in a competition among 125 students for her research on a lethal type of pediatric brain tumor called atypical teratoid/rhabdoid tumors (AT/RT), the most common brain tumor type in infants. The award was presented at the AACR 2017 annual meeting in Washington, D.C., on April 2. […]
Training the next generation of cancer immunotherapy experts
Posted by | treatmentJiajia Zhang was a trained oncologist in China when she read news about former Vice President Joe Biden's visit to Johns Hopkins and the launch of the Bloomberg-Kimmel Institute. "I want to make more of an impact in patients' lives, and I believe immunotherapy is the future of cancer treatment," says Zhang. She decided to […]
How do experts assess ‘chemo brain’?
Posted by | treatment*The information in this blog post is based on the webinar, “Understanding Cancer-related Cognitive Impairment,” hosted by the Kimmel Cancer Center's Breast Cancer Program. Q: What type of cognitive assessments can be done for cancer patients undergoing treatment or who have completed treatment who complain about ‘chemo brain’? A: Tracy Vannorsdall, Ph.D., a neuropsychologist at Johns Hopkins […]
Top Questions Ahead for Cancer Immunotherapy
Posted by | ResearchA decade ago, Suzanne Topalian, M.D., led a team of researchers who made an astonishing contribution to how cancer is fought. Many cancers can “put the brakes” on the body’s immune cells — cells that would normally storm into a tumor and destroy it. Topalian, director of the Melanoma Program at the Johns Hopkins Kimmel […]
8 Tips for Improving Cognition During and After Cancer Treatment
Posted by | Survivorship, treatment*The information in this blog post is based on the webinar, “Understanding Cancer-related Cognitive Impairment,” hosted by the Kimmel Cancer Center's Breast Cancer Program. Q: What can I do to improve my cognition during and after cancer treatment? A: Use areas of cognitive strength to compensate for any weaknesses, advises Tracy Vannorsdall, PhD, a neuropsychologist at […]
Research from Bloomberg-Kimmel Institute Among Best of #ASCO2017
Posted by | ResearchMore than 20 years ago, when Johns Hopkins scientists Bert Vogelstein, Ken Kinzler and their colleagues linked certain cancers to mutations in genes that repair DNA, they may not have imagined that their findings would spark an idea that has become a crystal ball for predicting whether immunotherapy is more likely to work in a person […]
Ulman Fund breaks ground on residence for young adults with cancer
Posted by | Childhood CancerOn a block of vacant row homes near the Johns Hopkins Medicine campus in East Baltimore, the Ulman Cancer Fund is building an 8,000 square-foot residence for young adults being treated for cancer. It will serve as a "home away from home" for people 15 to 39 who come from a distance to be treated […]
Kimmel Cancer Center Director Moderates AACR Webinar on Cancer Screening Guidelines
Posted by | Prevention/ScreeningWhat cancer screenings do I need and when? If this answer isn't clear to you, listen to Kimmel Cancer Center director William Nelson moderate a webinar on "Making Sense of Cancer Screening Guidelines," hosted by the American Association for Cancer Research and Cancer Today magazine. Nelson and his co-panelists will summarize the guidelines and provide their […]
What’s next for bladder cancer research?
Posted by | ResearchThe Johns Hopkins Greenberg Bladder Cancer Institute recently announced a joint effort with the Bladder Cancer Advocacy Network (BCAN) to fund up to two awards totaling $100,000 for young scientists. As part of the announcement, the Institute's director, David McConkey, Ph.D., gave us his thoughts on recent bladder cancer advances and ongoing research. Recent advances, says McConkey, include […]